Le protéasome, la seconde vie d’une cible thérapeutique validée : aspects structuraux et nouveaux inhibiteurs
Biologie Aujourd’hui, 215 1-2 (2021) 1-23
Published online: 2021-08-16
Articles citing this article
The Citing articles tool gives a list of articles citing the current article.
The citing articles come from EDP Sciences database, as well as other publishers participating in CrossRef Cited-by Linking Program. You can set up your personal account to receive an email alert each time this article is cited by a new article (see the menu on the right-hand side of the abstract page).
Cited article:
This article has been cited by the following article(s):
Efficient Synthesis and Biological Evaluation of 1,4-Disubstituted 3-Cyanopyridin-2(1H)-ones as Selective Inhibitors of the Post-Acid Activity of Mammalian 20S Proteasomes
L. V. Karapetyan, G. G. Tokmajyan, G. S. Melikyan, M. Bouvier-Durand, M. Reboud-Ravaux and T. H. PhamRussian Journal of Organic Chemistry 61 (3) 449 (2025)
https://doi.org/10.1134/S107042802460373X
Induction de proximité et dégradation de cibles thérapeutiques par les nouveaux dégradeurs : quels concepts, quels développements, quel futur ?
Michèle Reboud-RavauxBiologie Aujourd’hui 218 (1-2) 41 (2024)
https://doi.org/10.1051/jbio/2024007
The role of proteasome in muscle wasting of experimental arthritis
Vivian Oliveira Nunes Teixeira, Bárbara Jonson Bartikoski, Rafaela Cavalheiro do Espirito Santo, et al.Advances in Rheumatology 63 (1) (2023)
https://doi.org/10.1186/s42358-023-00292-5
Dégradation induite des protéines par des molécules PROTAC et stratégies apparentées : développements à visée thérapeutique
Michèle Reboud-RavauxBiologie Aujourd’hui 215 (1-2) 25 (2021)
https://doi.org/10.1051/jbio/2021007